info@3D-DXA.com

 

Exposing fraud with 3D-DXA

There has been a large amount of misinformation put forward by companies that are trying exploit 3D-DXA commercially. This trend may ultimately lead to false diagnoses and misinformation about disease progression and drug responses. I have therefore decided to devote this website to debunking these false claims and exposing scientific misconduct with 3D-DXA wherever I find it. I will no longer provide my software and strongly advice you to avoid the use of 3D-DXA at all costs. An explanation on the limitations of this technology are provided in the technology section and I will periodically update my blog with reports on its misuse.

Latest blog posts

24Apr

Financial settlement / muzzle contract

0 Comments
After the threats by DMS-Apelem and the apparent involvement of the Universitat Pompeu Fabra (UPF), I wanted to to have... Read More →
13Apr

Shit in, shit out. [Pardon my French]

0 Comments
The title of this blog refers to a question I once asked a video editor. I was disappointed about the... Read More →

Contact us

Please contact us if you suspect that you might have been diagnosed by a DXA Device from DMS-Apelem using the 3D-DXA software. Also please contact us if you purchased the 3D-DXA software with a DXA device under false pretences or outsourced a 3D-DXA analysis to Galgo Medical.

Notice

3D-DXA is not FDA approved. Results derived from 3D-DXA should not be used for diagnosis or treatment planning nor should they be used for research into disease progression or drug response. In doing so you may be held liable for medical malpractice or scientific misconduct.

Back to Top
3D-DXA by the inventor

Please be aware that The Pompeu Fabra University, Galgo Medical, and Diagnostic Medical Systems are currently under investigation regarding the illegal commercialization of the PhD work of Tristan Whitmarsh. Any publications using the 3D-DXA software provided by them will result in an inquiry which may lead to its retraction. For further information please use the contact form.